[1]
C. . David-Onuoha, “Transition to Pediatric Dolutegravir: A Before and After Study of Virologic Suppression Rate Among Pediatric Treatment Cohort in Rivers State, Nigeria”, TNHJ, vol. 26, no. 2, pp. 545–552, Jul. 2026, doi: 10.71637/tnhj.v26i2.1272.